<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-17T10:26:13Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/7444" metadataPrefix="didl">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/7444</identifier><datestamp>2026-02-06T12:53:36Z</datestamp><setSpec>com_10259_4363</setSpec><setSpec>com_10259_5086</setSpec><setSpec>com_10259_2604</setSpec><setSpec>com_10259_3924</setSpec><setSpec>com_10259.4_2516</setSpec><setSpec>com_10259_3592</setSpec><setSpec>com_10259_3591</setSpec><setSpec>com_10259.4_106</setSpec><setSpec>col_10259_4364</setSpec><setSpec>col_10259_3925</setSpec><setSpec>col_10259.4_2517</setSpec><setSpec>col_10259_3930</setSpec></header><metadata><d:DIDL xmlns:d="urn:mpeg:mpeg21:2002:02-DIDL-NS" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd">
<d:DIDLInfo>
<dcterms:created xmlns:dcterms="http://purl.org/dc/terms/" xsi:schemaLocation="http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/dcterms.xsd">2023-02-13T11:43:03Z</dcterms:created>
</d:DIDLInfo>
<d:Item id="hdl_10259_7444">
<d:Descriptor>
<d:Statement mimeType="application/xml; charset=utf-8">
<dii:Identifier xmlns:dii="urn:mpeg:mpeg21:2002:01-DII-NS" xsi:schemaLocation="urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd">urn:hdl:10259/7444</dii:Identifier>
</d:Statement>
</d:Descriptor>
<d:Descriptor>
<d:Statement mimeType="application/xml; charset=utf-8">
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title>Rational design of mitochondria targeted thiabendazole-based Ir(III) biscyclometalated complexes for a multimodal photodynamic therapy of cancer</dc:title>
<dc:creator>Echevarría Poza, Igor</dc:creator>
<dc:creator>Zafon, Elisenda</dc:creator>
<dc:creator>Barrabés, Sílvia</dc:creator>
<dc:creator>Martínez, María Ángeles</dc:creator>
<dc:creator>Ramos Gómez, Sonia</dc:creator>
<dc:creator>Ortega Santamaría, Natividad</dc:creator>
<dc:creator>Manzano, Blanca R.</dc:creator>
<dc:creator>Jalón Sotés, Félix Ángel</dc:creator>
<dc:creator>Quesada Pato, Roberto</dc:creator>
<dc:creator>Espino Ordóñez, Gustavo</dc:creator>
<dc:creator>Massaguer Vall-Llovera, Anna</dc:creator>
<dc:subject>Photodynamic therapy</dc:subject>
<dc:subject>Iridium</dc:subject>
<dc:subject>Cyclometalated complexes</dc:subject>
<dc:subject>Cancer</dc:subject>
<dc:subject>Mitochondria</dc:subject>
<dc:subject>DNA</dc:subject>
<dc:description>Despite their outstanding properties as potential photosensitizers for photodynamic therapy (PDT), Ir(III) biscyclometalated complexes need both further developments to overcome remaining limitations and in-depth&#xd;
investigations into their mechanisms of action to reach clinic application in the treatment of cancer. This&#xd;
work describes the synthesis of a family of Ir(III) complexes of general formula [Ir(C^N)2(N^N′&#xd;
)]Cl (N^N′ =&#xd;
thiabendazole-based ligands; C^N = ppy (2-phenylpyridinate) (Series A), or dfppy (2-(2,4-difluorophenyl)pyridinate) (Series B)) and their evaluation as potential PDT agents. These complexes are partially soluble in water&#xd;
and exhibit cytotoxic activity in the absence of light irradiation versus several cancer cell lines. Furthermore, the&#xd;
cytotoxic activity of derivatives of Series A is enhanced upon irradiation, particularly for complexes [1a]Cl and&#xd;
[3a]Cl, which show phototoxicity indexes (PI) above 20. Endocytosis was established as the uptake mechanism&#xd;
for [1a]Cl and [3a]Cl in prostate cancer cells by flow cytometry. These derivatives mainly accumulate in the&#xd;
mitochondria as shown by colocalization confocal microscopy experiments. Presumably, [1a]Cl and [3a]Cl&#xd;
induce death on cancer cells under irradiation through apoptosis triggered by a multimodal mechanism of action,&#xd;
which likely involves damage over mitochondrial DNA and mitochondrial membrane depolarization. Both&#xd;
processes seem to be the result of photocatalytic oxidation processes.</dc:description>
<dc:date>2023-02-13T11:43:03Z</dc:date>
<dc:date>2023-02-13T11:43:03Z</dc:date>
<dc:date>2022-06</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:identifier>0162-0134</dc:identifier>
<dc:identifier>http://hdl.handle.net/10259/7444</dc:identifier>
<dc:identifier>10.1016/j.jinorgbio.2022.111790</dc:identifier>
<dc:language>eng</dc:language>
<dc:relation>Journal of Inorganic Biochemistry. 2022, V. 231, 111790</dc:relation>
<dc:relation>https://doi.org/10.1016/j.jinorgbio.2022.111790</dc:relation>
<dc:relation>info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RTI2018-100709-B-C21/ES/NUEVOS METALOFARMACOS DISEÑADOS PARA INCREMENTAR LA SELECTIVIDAD EN TRATAMIENTOS CONTRA EL CANCER. USO DE FOTOTERAPIA Y VEHICULIZACION CON LIGANDOS DIRIGIDOS A TUMORES/</dc:relation>
<dc:relation>info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RTI2018-100709-B-C22/ES/NUEVOS METALOFARMACOS DISEÑADOS PARA INCREMENTAR LA SELECTIVIDAD. USO DE FOTOTERAPIA Y VEHICULIZACION CON LIGANDOS DIRIGIDOS A TUMORES/</dc:relation>
<dc:relation>info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RED2018-102471-T/ES/METALOFARMACOS MULTIFUNCIONALES PARA DIAGNOSIS Y TERAPIA/</dc:relation>
<dc:relation>info:eu-repo/grantAgreement/Junta de Castilla y León//BU087G19//Compuestos organometálicos de ir(iii) en terapias antiproliferativas y como sondas químicas deaminas biógenas/</dc:relation>
<dc:relation>info:eu-repo/grantAgreement/JCCM//SBPLY%2F19%2F180501%2F000260/</dc:relation>
<dc:relation>info:eu-repo/grantAgreement/UCLM//2019-GRIN-27183/</dc:relation>
<dc:relation>info:eu-repo/grantAgreement/UCLM//2019-GRIN-27209/</dc:relation>
<dc:relation>info:eu-repo/grantAgreement/AGAUR//2021 FI_B 01036/</dc:relation>
<dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 Internacional</dc:rights>
<dc:publisher>Elsevier</dc:publisher>
</oai_dc:dc>
</d:Statement>
</d:Descriptor>
<d:Component id="10259_7444_1">
<d:Resource ref="https://riubu.ubu.es/bitstream/10259/7444/1/Echevarria-jib_2022.pdf" mimeType="application/pdf"/>
</d:Component>
</d:Item>
</d:DIDL></metadata></record></GetRecord></OAI-PMH>